कृपया अन्य खोज का प्रयास करें
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, Contract Development and Manufacturing Organization Business, and Biopharmaceutical Development and Commercialization Business. It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Changwoo Lee | 53 | - | Independent Director |
Kyunghee Kim | 63 | 2020 | Independent Outside Director |
Geunnyeong Heo | 67 | 2019 | Independent Director |
Dogeol Ahn | - | 2023 | Independent Director |
Jaewan Bahk | 68 | 2022 | Independent Director |
Dong-Joong Kim | 58 | 2014 | CFO, Executive VP, MD & Director |
John Chongbo Rim | 62 | 2019 | CEO, President & Chairman of Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है